<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>349</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>15470026</PubmedId>
            <Abstract>The pathology of ankylosing spondylitis, reactive arthritis, and other spondyloarthropathies (SpA) is closely associated with the human leukocyte class I Ag HLA-B27. A characteristic finding in SpA is inflammation of cartilage structures of the joint, in particular at the site of ligament/tendon and bone junction (enthesitis). In this study, we investigated the role of CD8+ T cells in response to the cartilage proteoglycan aggrecan as a potential candidate autoantigen in BALB/c-B27 transgenic mice. We identified four new HLA-B27-restricted nonamer peptides, one of them (no. 67) with a particularly strong T cell immunogenicity. Peptide no. 67 immunization was capable of stimulating HLA-B27-restricted, CD8+ T cells in BALB/c-B27 transgenic animals, but not in wild-type BALB/c mice. The peptide was specifically recognized on P815-B27 transfectants by HLA-B27-restricted CTLs, which were also detectable by HLA tetramer staining ex vivo as well as in situ. Most importantly, analysis of the joints from peptide no. 67-immunized mice induced typical histological signs of SpA. Our data indicate that HLA-B27-restricted epitopes derived from human aggrecan are involved in the induction of inflammation (tenosynovitis), underlining the importance of HLA-B27 in the pathogenesis of SpA.</Abstract>
            <ArticleYear>2004</ArticleYear>
            <ArticlePages>4859-66</ArticlePages>
            <ArticleTitle>Identification of novel human aggrecan T cell epitopes in HLA-B27 transgenic mice associated with spondyloarthropathy.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Kuon</LastName>
                    <ForeName>Wolfgang</ForeName>
                </Author>
                <Author>
                    <LastName>Kuhne</LastName>
                    <ForeName>Maren</ForeName>
                </Author>
                <Author>
                    <LastName>Busch</LastName>
                    <ForeName>Dirk H</ForeName>
                </Author>
                <Author>
                    <LastName>Atagunduz</LastName>
                    <ForeName>Pamir</ForeName>
                </Author>
                <Author>
                    <LastName>Seipel</LastName>
                    <ForeName>Martina</ForeName>
                </Author>
                <Author>
                    <LastName>Wu</LastName>
                    <ForeName>Peihua</ForeName>
                </Author>
                <Author>
                    <LastName>Morawietz</LastName>
                    <ForeName>Lars</ForeName>
                </Author>
                <Author>
                    <LastName>Fernahl</LastName>
                    <ForeName>Gabriele</ForeName>
                </Author>
                <Author>
                    <LastName>Appel</LastName>
                    <ForeName>Heiner</ForeName>
                </Author>
                <Author>
                    <LastName>Weiss</LastName>
                    <ForeName>Elisabeth H</ForeName>
                </Author>
                <Author>
                    <LastName>Krenn</LastName>
                    <ForeName>Veit</ForeName>
                </Author>
                <Author>
                    <LastName>Sieper</LastName>
                    <ForeName>Joachim</ForeName>
                </Author>
            </Authors>
            <Affiliations>Department of Gastroenterology and Rheumatology, Charité-Universitätsmedizin, Berlin, Germany. kuon@medizin.fu-berlin.de.</Affiliations>
            <ArticleChemicalList>Acan protein, mouse;Aggrecans;Epitopes, T-Lymphocyte;Extracellular Matrix Proteins;HLA-B27 Antigen;Lectins, C-Type;Proteoglycans</ArticleChemicalList>
            <ArticleMeshHeadingsList>Aggrecans; Animals; Arthritis, Reactive(etiology); Binding Sites; CD8-Positive T-Lymphocytes(immunology); Epitopes, T-Lymphocyte; Extracellular Matrix Proteins(immunology); Female; HLA-B27 Antigen(physiology); Immunization; Lectins, C-Type; Mice; Mice, Inbred BALB C; Mice, Transgenic; Proteoglycans(immunology); Spondylarthropathies(etiology); Spondylitis, Ankylosing(etiology); Tenosynovitis(etiology)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>173</Volume>
                <Issue>8</Issue>
                <Title>Journal of immunology (Baltimore, Md. : 1950)</Title>
                <Issn>0022-1767</Issn>
                <MedlineTa>J Immunol</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>human aggrecan peptide no.67</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>SRHHAFCFR</LinearSequence>
                        <StartingPosition>666</StartingPosition>
                        <EndingPosition>674</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P16112.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9606</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Materials and methods</LocationOfData>
                <EpitopeId>60693</EpitopeId>
                <EpitopeEvidenceCode>Author provided Identifier</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 10</LocationOfData>
                        <TCellId>1847875</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000008</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-12 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo to cause disease</InVivoProcessType>
                                <DiseaseState>DOID:0060039</DiseaseState>
                                <DiseaseStage>Acute/Recent onset</DiseaseStage>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>SRHHAFCFR</LinearSequence>
                                            <StartingPosition>666</StartingPosition>
                                            <EndingPosition>674</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P16112.2</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>9606</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>peptide 67</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>4-6 doses of 100 µg, administered at 2-week intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice were immunized with a peptide pool containing the epitope.  The first immunization was with CFA, and the remaining 3-5  immunizations were with IFA.  Time between immunizations was about 2 weeks.</ImmunizationComments>
                        </Immunization>
                        <MhcAllele>
                            <MhcAlleleId>280</MhcAlleleId>
                            <MhcEvidenceCode>Cited reference</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Structurally Related</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>NP_031450.2</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>346</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Epitope immunization induced tenosynovitis in B27-transgenic mice as shown by tendon sheath being enlarged, edematous, and infiltrated by lymphocytes.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 6, 8 and 9</LocationOfData>
                        <TCellId>1847868</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000008</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-12 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>SRHHAFCFR</LinearSequence>
                                            <StartingPosition>666</StartingPosition>
                                            <EndingPosition>674</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P16112.2</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>9606</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>peptide 67</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>4-6 doses of 100 µg, administered at 2-week intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>Splenocyte</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>SRHHAFCFR</LinearSequence>
                                            <StartingPosition>666</StartingPosition>
                                            <EndingPosition>674</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P16112.2</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>9606</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Mice were immunized with a peptide pool containing the epitope.  The first immunization was with CFA, and the remaining 3-5  immunizations were with IFA.  Time between immunizations was about 2 weeks.  Spleens were taken one week after last immunization.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <MhcAllele>
                            <MhcAlleleId>280</MhcAlleleId>
                            <MhcEvidenceCode>Cited reference</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>peptide 67</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SRHHAFCFR</LinearSequence>
                                        <StartingPosition>666</StartingPosition>
                                        <EndingPosition>674</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P16112.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>47</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Short-term stimulated CD8+ T cells and CD8+ T cells from cryosections of spleen tissues from immunized mice were positive for tetramer staining.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 1, 2, 4A and 7</LocationOfData>
                        <TCellId>519</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000008</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-12 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>SRHHAFCFR</LinearSequence>
                                            <StartingPosition>666</StartingPosition>
                                            <EndingPosition>674</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P16112.2</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>9606</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>peptide 67</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>4-6 doses of 100 µg, administered at 2-week intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice were immunized with a peptide pool containing the epitope.  The first immunization was with CFA, and the remaining 3-5  immunizations were with IFA.  Time between immunizations was about 2 weeks.  Spleens were taken one week after last immunization.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>280</MhcAlleleId>
                            <MhcEvidenceCode>Cited reference</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>peptide 67</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SRHHAFCFR</LinearSequence>
                                        <StartingPosition>666</StartingPosition>
                                        <EndingPosition>674</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P16112.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>53</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Ex vivo splenic CD8+ T cells and short-term restimulated CD8+ T cells showed the same results.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 3 and 5</LocationOfData>
                        <TCellId>1847854</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000008</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-12 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>SRHHAFCFR</LinearSequence>
                                            <StartingPosition>666</StartingPosition>
                                            <EndingPosition>674</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P16112.2</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>9606</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>peptide 67</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>4-6 doses of 100 µg, administered at 2-week intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice were immunized with a peptide pool containing the epitope.  The first immunization was with CFA, and the remaining 3-5  immunizations were with IFA.  Time between immunizations was about 2 weeks.  Spleens were taken one week after last immunization.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Other</CellTissueType>
                            <CellType>P815-Mast cell</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>280</MhcAlleleId>
                            <MhcEvidenceCode>Cited reference</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>peptide 67</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SRHHAFCFR</LinearSequence>
                                        <StartingPosition>666</StartingPosition>
                                        <EndingPosition>674</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P16112.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Epitope-specific CTL lysed epitope-loaded P815-B27 target cells.  Ex vivo splenic CD8+ T cells and short-term restimulated CD8+ T cells showed the same results.  Wild-type Balb/c mice were negative.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>mouse aggrecan peptide no.67</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>SKHHAFCFR</LinearSequence>
                        <StartingPosition>676</StartingPosition>
                        <EndingPosition>684</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>NP_031450.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10090</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Text p.4862</LocationOfData>
                <EpitopeId>58844</EpitopeId>
                <EpitopeEvidenceCode>Author provided Identifier</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4B</LocationOfData>
                        <TCellId>7601</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000008</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-12 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>SKHHAFCFR</LinearSequence>
                                            <StartingPosition>676</StartingPosition>
                                            <EndingPosition>684</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>NP_031450.2</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10090</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Pep#67(M)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>4-6 doses of 100 µg, administered at 2-week intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice were immunized with a peptide pool containing the epitope.  The first immunization was with CFA, and the remaining 3-5  immunizations were with IFA.  Time between immunizations was about 2 weeks.  Spleens were taken one week after last immunization.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>626</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -T cell subset identification</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Pep#67(M)</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SKHHAFCFR</LinearSequence>
                                        <StartingPosition>676</StartingPosition>
                                        <EndingPosition>684</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>NP_031450.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>53</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4D</LocationOfData>
                        <TCellId>8246</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-12 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>SKHHAFCFR</LinearSequence>
                                            <StartingPosition>676</StartingPosition>
                                            <EndingPosition>684</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>NP_031450.2</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10090</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Pep#67(M)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>4-6 doses of 100 µg, administered at 2-week intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice were immunized with a peptide pool containing the epitope.  The first immunization was with CFA, and the remaining 3-5  immunizations were with IFA.  Time between immunizations was about 2 weeks.  Spleens were taken one week after last immunization.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>169</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -T cell subset identification</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Pep#67(M)</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SKHHAFCFR</LinearSequence>
                                        <StartingPosition>676</StartingPosition>
                                        <EndingPosition>684</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>NP_031450.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>53</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

